Participation of the serotonin system in rofecoxib-induced antinociception.
Déciga-Campos
Myrna
M
Departamento de Farmacobiologia, CINVESTAV-IPN, México DF.
Díaz-Reval
María Irene
MI
Ventura-Martínez
Rosa
R
López-Muñoz
Francisco J
FJ
D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D005260:Female; D006930:Hyperalgesia / Q000139:chemically induced / Q000188:drug therapy; D007211:Indoles / Q000008:administration & dosage / Q000494:pharmacology; D007276:Injections, Intraventricular; D007650:Ketanserin / Q000008:administration & dosage / Q000494:pharmacology; D007783:Lactones / Q000494:pharmacology*; D010147:Pain Measurement / Q000187:drug effects; D051381:Rats; D044406:Receptors, Serotonin, 5-HT3 / Q000187:drug effects; D044422:Receptors, Serotonin, 5-HT4 / Q000187:drug effects; D012701:Serotonin / Q000502:physiology*; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology*; D000077526:Tropisetron; D014527:Uric Acid
D000700:Analgesics; D016861:Cyclooxygenase Inhibitors; D007211:Indoles; D007783:Lactones; D044406:Receptors, Serotonin, 5-HT3; D012702:Serotonin Antagonists; D013450:Sulfones; C116926:rofecoxib; D044422:Receptors, Serotonin, 5-HT4; D014527:Uric Acid; D012701:Serotonin; D000077526:Tropisetron; D007650:Ketanserin